<http://schema.org/description>
"A suite of next-generation drugs has propelled Isis shares way higher in the past year. Is there still room to run?"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2013/09/10/isis-scores-another-big-biotech-deal-with-biogen.aspx>